Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study

Open access
Matsumura-Nakano, Yukiko, Shizuta, Satoshi, Komasa, Akihiro, Morimoto, Takeshi, Masuda, Hisaki, Shiomi, Hiroki, Goto, Koji, Nakai, Kentaro, Ogawa, Hisashi, Kobori, Atsushi, Kono, Yutaka, Kaitani, Kazuaki, Suwa, Satoru, Aoyama, Takeshi, Takahashi, Mamoru, Sasaki, Yasuhiro, Onishi, Yuko, Mano, Toshiaki, Matsuda, Mitsuo, Motooka, Makoto, Tomita, Hirofumi, Inoko, Moriaki, Wakeyama, Takatoshi, Hagiwara, Nobuhisa, Tanabe, Kengo, Akao, Masaharu, Miyauchi, Katsumi, Yajima, Junji, Hanaoka, Keiichi, Morino, Yoshihiro, Ando, Kenji, Furukawa, Yutaka, Nakagawa, Yoshihisa, Nakao, Koichi, Kozuma, Ken, Kadota, Kazushige, Kimura, Kazuo, Kawai, Kazuya, Ueno, Takafumi, Okumura, Ken, Kimura, Takeshi, On behalf of the OAC-ALONE Study Investigators · 2019 · Circulation

Abstract

Background: Despite recommendations in the guidelines and consensus documents, there has been no randomized controlled trial evaluating oral anticoagulation (OAC) alone without antiplatelet therapy (APT) in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stenting. Methods: This study was a prospective, multicenter, open-label, noninferiority trial comparing OAC alone to combined OAC and single APT among patients with atrial fibrillation beyond 1 year after stenting in a 1:1 randomization fashion. The primary end point was a composite of all-cause death, myocardial infarction, stroke, or systemic embolism. The major secondary end point was a composite of the primary end point or major bleeding according to the International Society on Thrombosis and Haemostasis classification. Although the trial was designed to enroll 2000 patients during 12 months, enrollment was prematurely terminated after enrolling 696 patients in 38 months. Results: Mean age was 75.0±7.6 years, and 85.2% of patients were men. OAC was warfarin in 75.2% and direct oral anticoagulants in 24.8% of patients. The mean CHADS 2 score was 2.5±1.2. During a median follow-up interval of 2.5 years, the primary end point occurred in 54 patients (15.7%) in the OAC-alone group and in 47 patients (13.6%) in the combined OAC and APT group (hazard ratio, 1.16; 95% CI, 0.79–1.72; P =0.20 for noninferiority, P =0.45 for superiority). The major secondary end point occurred in 67 patients (19.5%) in the OAC-alone group and in 67 patients (19.4%) in the combined OAC and APT group (hazard ratio, 0.99; 95% CI, 0.71–1.39; P =0.016 for noninferiority, P =0.96 for superiority). Myocardial infarction occurred in 8 (2.3%) and 4 (1.2%) patients, whereas stroke or systemic embolism occurred in 13 (3.8%) and 19 (5.5%) patients, respectively. Major bleeding occurred in 27 (7.8%) and 36 (10.4%) patients, respectively. Conclusions: This randomized trial did not establish noninferiority of OAC alone to combined OAC and APT in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after stenting. Because patient enrollment was prematurely terminated, the study was underpowered and inconclusive. Future larger studies are required to establish the optimal antithrombotic regimen in this population. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01962545.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.036768

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 207

Metadata

Authors
Matsumura-Nakano, Y., Shizuta, S., Komasa, A., Morimoto, T., Masuda, H., Shiomi, H., Goto, K., Nakai, K., Ogawa, H., Kobori, A., Kono, Y., Kaitani, K., Suwa, S., Aoyama, T., Takahashi, M., Sasaki, Y., Onishi, Y., Mano, T., Matsuda, M., Motooka, M., Tomita, H., Inoko, M., Wakeyama, T., Hagiwara, N., Tanabe, K., Akao, M., Miyauchi, K., Yajima, J., Hanaoka, K., Morino, Y., Ando, K., Furukawa, Y., Nakagawa, Y., Nakao, K., Kozuma, K., Kadota, K., Kimura, K., Kawai, K., Ueno, T., Okumura, K., Kimura, T., & On behalf of the OAC-ALONE Study Investigators
Venue
Circulation
Published
2019-01-29
Volume
139
Issue
5
Pages
604-616
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3013680585
Cited by
207
References
15
FWCI
17.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study. https://app.cochat.ai/papers/10.1161/circulationaha.118.036768
The paper
Matsumura-Nakano, Y., Shizuta, S., Komasa, A., Morimoto, T., Masuda, H., Shiomi, H., Goto, K., Nakai, K., Ogawa, H., Kobori, A., Kono, Y., Kaitani, K., Suwa, S., Aoyama, T., Takahashi, M., Sasaki, Y., Onishi, Y., Mano, T., Matsuda, M., . . . On behalf of the OAC-ALONE Study Investigators. (2019). Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study. Circulation. https://doi.org/10.1161/circulationaha.118.036768

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.